EVERSUN: a phase 2 trial of alternating sunitinib and everolimus as first-line therapy for advanced renal cell carcinoma - Concepedia

Concepedia

Publication | Open Access

EVERSUN: a phase 2 trial of alternating sunitinib and everolimus as first-line therapy for advanced renal cell carcinoma

DOI Full Paper Access

14

Citations

10

References

2015

Year

Ian D. Davis, A. Long, Sonia Yip, D. Espinoza, J THOMPSON, Ganessan Kichenadasse, Michelle Harrison, Ray M. Lowenthal, Nick Pavlakis, Arun Azad,

Annals of Oncology

First-line TherapyUrologyGenitourinary CancerMedicineImmune Checkpoint InhibitorCancer TreatmentPhase 2OncologyRadiation Oncology

References

	Year	Citations

Page 1

Page 1